BUCKMAN PAUL 4
4 · NEUROONE MEDICAL TECHNOLOGIES Corp · Filed Apr 7, 2026
Research Summary
AI-generated summary of this filing
NeuroOne (NMTC) Director Paul Buckman Receives Award
What Happened Paul Buckman, a director of NeuroOne Medical Technologies Corp (NMTC), received two awards on April 3, 2026: 41,929 restricted stock units (RSUs) and 26,036 derivative units/options. Both awards were granted at $0.00 (typical for equity grants) and will vest in equal monthly installments over a one‑year period.
Key Details
- Transaction date: 2026-04-03; Filing date (Form 4): 2026-04-07 (filing not marked as late in the report)
- Awards: 41,929 RSUs (grant) and 26,036 derivative units/options (grant)
- Price: $0.00 per share for both awards (no cash paid)
- Vesting: Both awards vest in 12 equal monthly installments over one year (F1 and F2)
- Shares owned after transaction: Not specified in the provided filing excerpt
- Transaction type codes: A = Award/Grant; derivative entry indicates an option or other equity derivative
Context
- These are grants (compensation/equity awards), not open‑market purchases or sales, so they do not by themselves signal buying or selling intent in the market.
- The derivative award is described as an option-like instrument that vests monthly; it does not indicate an immediate exercise or sale.
Insider Transaction Report
Form 4
BUCKMAN PAUL
Director
Transactions
- Award
Common Stock
[F1]2026-04-03+41,929→ 178,733 total - Award
Option to Purchase Common Stock
[F2]2026-04-03+26,036→ 26,036 totalExercise: $0.80Exp: 2036-04-02→ Common Stock (26,036 underlying)
Footnotes (2)
- [F1]Represents a grant of restricted stock units, which vest in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
- [F2]The option vests in 12 equal monthly installments over a one-year period, with such vesting to occur at the end of each month.
Signature
/s/ Emily Johns, by Power of Attorney|2026-04-07